BOSTON & WATERLOO, Ontario--(BUSINESS WIRE)--Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics Inc., a leader in label-free optical imaging and ...
LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader ...
Chicago, IL, April 21, 2025 (GLOBE NEWSWIRE) -- DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force in artificial intelligence-driven ...
International medical technology and cybersecurity company Sectra (STO: SECT B), in collaboration with distribution partner Matsunami Glass has commenced the implementation phase of its first digital ...
Washington, DC, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata ®, Inc. announced today that it has finalized an agreement with Leica ...
The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now cleared to aid in clinical diagnosis, enabling pathologists to diagnose ...
Digital pathology has a crucial role in diagnostic pathology and is increasingly a technological requirement in the field. Integration of digital slides into the pathology workflow, advanced ...
As the demand for pathology-based diagnoses rises, particularly with the growth of personalised cancer care, improved workflow efficiency allows pathologists to manage their growing caseloads more ...
PORTSMOUTH, N.H. & KALAMAZOO, Mich.--(BUSINESS WIRE)--Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and ...
The VENTANA DP 600 slide scanner, part of Roche's Digital Pathology Dx system, is now cleared by the FDA to aid in clinical diagnosis, enabling pathologists to diagnose patients using digital images.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results